http://avelox.legalview.com/msn/ 2012-02-23 http://avelox.legalview.com/msn/molecular-partners-completes-mp0112-phase-iiia-trials-in-wet-amd-dme/1333798/ 2012-02-23 http://avelox.legalview.com/msn/reportlinker-adds-forecast-insight-antibacterials/1333797/ 2012-02-23 http://avelox.legalview.com/msn/maxwell-biotech-sequella-enter-license-agreement-to-commercialize-sq10/1333063/ 2012-02-23 http://avelox.legalview.com/msn/periodontal-disease-medications/1333062/ 2012-02-23 http://avelox.legalview.com/msn/treatment-of-pelvic-inflammatory-disease-etiology-of-pid/1333061/ 2012-02-23 http://avelox.legalview.com/msn/treatment-of-pelvic-inflammatory-disease-treatment/1333060/ 2012-02-23 http://avelox.legalview.com/msn/optimer-drug-to-face-fda-panel/1333059/ 2012-02-23 http://avelox.legalview.com/msn/avelox-has-taken-my-life-away/1332635/ 2012-02-23 http://avelox.legalview.com/msn/rumor-imacs-with-sandy-bridge-thunderbolt-due-in-may/1332170/ 2012-02-23 http://avelox.legalview.com/msn/antibiotic-overuse-in-the-us-population/1332169/ 2012-02-23 http://avelox.legalview.com/msn/watson-pharma-confirms-vigamox-patent-challenge-quick-facts/1330381/ 2012-02-23 http://avelox.legalview.com/msn/fda-sends-inspire-pharmaceuticals-letter-regarding-azasite-promotional/1329823/ 2012-02-23 http://avelox.legalview.com/msn/optimer-drug-to-face-fda-panel/1325715/ 2012-02-23 http://avelox.legalview.com/msn/post-game-thread-giants-coast-to-easy-victory-in-home-opener-against-c/1323878/ 2012-02-23 http://avelox.legalview.com/msn/occult-primary-tumors-chemotherapy-regimens/1323877/ 2012-02-23 http://avelox.legalview.com/msn/watson-confirms-vigamox-patent-challenge/1323463/ 2012-02-23 http://avelox.legalview.com/msn/disseminated-tuberculosis/1323462/ 2012-02-23 http://avelox.legalview.com/msn/optimer-drug-to-face-fda-panel/1320989/ 2012-02-23 http://avelox.legalview.com/msn/optimer-drug-to-face-fda-panel/1319107/ 2012-02-23 http://avelox.legalview.com/msn/update-on-clostridium-difficile-infection-two-step-and-three-step-algo/1317643/ 2012-02-23 http://avelox.legalview.com/msn/watson-pharma-confirms-vigamox-patent-challenge-quick-facts/1317642/ 2012-02-23 http://avelox.legalview.com/msn/watson-bekrefter-patent-utfordringen-ved-alcon-for-generiske-vigamox/1317641/ 2012-02-23 http://avelox.legalview.com/msn/watson-bekraftar-patent-utmaning-av-alcon-for-generiska-vigamox/1317640/ 2012-02-23 http://avelox.legalview.com/msn/watson-wpi-affirms-filing-anda-for-generic-vigamox-acl/1317639/ 2012-02-23 http://avelox.legalview.com/msn/optimer-pharmaceuticals-appoints-glenn-tillotson-phd-to-senior-vice-pr/1316728/ 2012-02-23 http://avelox.legalview.com/msn/new-data-at-asco-show-novartis-drug-tasigna-surpasses-gleevec-for-newl/1316727/ 2012-02-23 http://avelox.legalview.com/msn/items-in-afp-with-mesh-term-sexually-transmitted-diseases/1316726/ 2012-02-23 http://avelox.legalview.com/msn/symlinpen-120-subq-interactions/1316725/ 2012-02-23 http://avelox.legalview.com/msn/reportlinker-adds-world-ophthalmic-pharmaceutical-market-2010-2025/1316724/ 2012-02-23 http://avelox.legalview.com/msn/glucose-homeostasis-abnormalities-associated-with-use-of-gatifloxacin/1316723/ 2012-02-23 http://avelox.legalview.com/msn/research-and-markets-moxifloxacin-comprehensive-patent-search/1316722/ 2012-02-23 http://avelox.legalview.com/msn/denture-cream-adhesive-lawsuits/1316721/ 2012-02-23 http://avelox.legalview.com/msn/yuriorkis-gamboa-to-fight-again-on-february-20/1316720/ 2012-02-23 http://avelox.legalview.com/msn/tequin-linked-to-high-risk-of-dangerous-glucose-changes/1316719/ 2012-02-23 http://avelox.legalview.com/msn/icaac-mice-fare-better-than-men-in-novel-tb-regimen/1316718/ 2012-02-23 http://avelox.legalview.com/msn/why-oscar-de-la-hoya-manny-pacquiao-will-go-global/1316717/ 2012-02-23 http://avelox.legalview.com/msn/generic-erosion-of-nine-branded-agents-will-significantly-constrain-gr/1316716/ 2012-02-23 http://avelox.legalview.com/msn/optimer-remains-neutral/1315833/ 2012-02-23 http://avelox.legalview.com/msn/recommendations-and-rationale-for-the-treatment-of-pelvic-inflammatory/1315283/ 2012-02-23 http://avelox.legalview.com/msn/optimer-drug-to-face-fda-panel/1315282/ 2012-02-23 http://avelox.legalview.com/msn/update-on-clostridium-difficile-infection-sidebar/1314859/ 2012-02-23 http://avelox.legalview.com/msn/update-on-clostridium-difficile-infection-newer-and-alternative-antibi/1314241/ 2012-02-23 http://avelox.legalview.com/msn/update-on-clostridium-difficile-infection-conclusion/1314240/ 2012-02-23 http://avelox.legalview.com/msn/the-dissonansnyj-subject-an-actual-national-problem/1314239/ 2012-02-23 http://avelox.legalview.com/msn/optimer-drug-to-face-fda-panel/1314238/ 2012-02-23 http://avelox.legalview.com/msn/effects-of-multistrain-probiotic-containing-yogurt-on-second-line-trip/1313605/ 2012-02-23 http://avelox.legalview.com/msn/update-on-clostridium-difficile-infection-risk-factors/1313604/ 2012-02-23 http://avelox.legalview.com/msn/antibiotic-overuse-in-the-us-population/1313027/ 2012-02-23 http://avelox.legalview.com/msn/famed-npr-voice-resonates-with-students/1312321/ 2012-02-23 http://avelox.legalview.com/msn/optimer-remains-neutral/1312320/ 2012-02-23 http://avelox.legalview.com/msn/optimer-drug-to-face-fda-panel/1311575/ 2012-02-23 http://avelox.legalview.com/msn/thank-you-thank-you-donna-donahue/1311180/ 2012-02-23 http://avelox.legalview.com/msn/local-lowdown/1311179/ 2012-02-23 http://avelox.legalview.com/msn/optimer-drug-to-face-fda-panel/1311178/ 2012-02-23 http://avelox.legalview.com/msn/antibiotic-treatment-does-not-benefit-patients-with-discoloured-phlegm/1309874/ 2012-02-23 http://avelox.legalview.com/msn/drug-supply-business-retreats-from-unattractive-market/1309309/ 2012-02-23 http://avelox.legalview.com/msn/new-medicines-knowledge-of-the-enemy-will-widen-our-armoury/1308032/ 2012-02-23 http://avelox.legalview.com/msn/drug-supply-business-retreats-from-unattractive-market/1308031/ 2012-02-23 http://avelox.legalview.com/msn/new-eu-funded-projects-to-combat-tuberculosis/1308030/ 2012-02-23 http://avelox.legalview.com/msn/gastroesophageal-reflux-disease-gerd/1308029/ 2012-02-23 http://avelox.legalview.com/msn/hydrocortisone-therapy-for-trauma-patients-associated-with-reduced-hos/1308028/ 2012-02-23 http://avelox.legalview.com/msn/south-africa-the-success-of-decentralising-dr-tb-treatment/1307573/ 2012-02-23 http://avelox.legalview.com/msn/week-16-nfl-predictions-seattle-seahawks-vs-tampa-bay-buccaneers-odds/1307572/ 2012-02-23 http://avelox.legalview.com/msn/nfl-predictions-week-12-san-diego-chargers-at-indianapolis-colts/1307571/ 2012-02-23 http://avelox.legalview.com/msn/risk-of-fluoroquinolone-associated-myasthenia-gravis-exacerbation-febr/1307570/ 2012-02-23 http://avelox.legalview.com/msn/optimer-remains-neutral/1307569/ 2012-02-23 http://avelox.legalview.com/msn/research-and-markets-moxifloxacin-comprehensive-patent-search/1306829/ 2012-02-23 http://avelox.legalview.com/msn/optr-astellas-pact-for-fidaxomicin/1305905/ 2012-02-23 http://avelox.legalview.com/msn/abdominal-pain-in-children/1305904/ 2012-02-23 http://avelox.legalview.com/msn/risk-of-fluoroquinolone-associated-myasthenia-gravis-exacerbation-febr/1305903/ 2012-02-23 http://avelox.legalview.com/msn/lavender-oil-has-potent-antifungal-effect/1305348/ 2012-02-23 http://avelox.legalview.com/msn/mens-basketball-rebounds-from-first-loss/1304022/ 2012-02-23 http://avelox.legalview.com/msn/heart-attack-part-two-a-patient-guide/1304021/ 2012-02-23 http://avelox.legalview.com/msn/belly-laugh-best-for-venous-leg-ulcers/1302924/ 2012-02-23 http://avelox.legalview.com/msn/precautions-and-side-effects/1302923/ 2012-02-23 http://avelox.legalview.com/msn/treatment-for-acute-sinusitis/1302922/ 2012-02-23 http://avelox.legalview.com/msn/new-drug-policy-to-curb-misuse-of-antibiotics/1300716/ 2012-02-23 http://avelox.legalview.com/msn/new-drug-policy-to-curb-misuse-of-antibiotics/1300053/ 2012-02-23 http://avelox.legalview.com/msn/map-pharmaceuticals-reports-2010-fourth-quarter-and-year-end-financial/1297422/ 2012-02-23 http://avelox.legalview.com/msn/map-pharmaceuticals-reports-2010-fourth-quarter-and-year-end-financial/1296061/ 2012-02-23 http://avelox.legalview.com/msn/how-to-minimize-the-side-effects-of-antibiotics/1295449/ 2012-02-23 http://avelox.legalview.com/msn/i-a-a-fable/1295002/ 2012-02-23 http://avelox.legalview.com/msn/bayer-mum-on-tendon-rupture-in-january-release/1293921/ 2012-02-23 http://avelox.legalview.com/msn/sinusitis-chronic-chronic-sinus-infection/1293292/ 2012-02-23 http://avelox.legalview.com/msn/experts-say-signs-and-treatment-of-bacterial-infection-often-misunders/1292149/ 2012-02-23 http://avelox.legalview.com/msn/clinical-data-inc-announces-vilazodone-data-presented-at-american-soci/1292148/ 2012-02-23 http://avelox.legalview.com/msn/toe-pain/1291631/ 2012-02-23 http://avelox.legalview.com/msn/gentium-announces-completion-of-preclinical-and-clinical-studies-for-d/1290252/ 2012-02-23 http://avelox.legalview.com/msn/ask-your-pharmacist/1290251/ 2012-02-23 http://avelox.legalview.com/msn/optimer-pharmaceuticals-appoints-glenn-tillotson-phd-to-senior-vice-pr/1289225/ 2012-02-23 http://avelox.legalview.com/msn/new-insight-into-amd-related-blindness/1287859/ 2012-02-23 http://avelox.legalview.com/msn/gentium-announces-completion-of-preclinical-and-clinical-studies-for-d/1286488/ 2012-02-23 http://avelox.legalview.com/msn/research-and-markets-moxifloxacin-comprehensive-patent-search/1286487/ 2012-02-23 http://avelox.legalview.com/msn/more-eye-disease-drug-trials-in-oculars-sights/1285889/ 2012-02-23 http://avelox.legalview.com/msn/alcon-posts-solid-fourth-quarter-financial-results/1285888/ 2012-02-23 http://avelox.legalview.com/msn/half-half-egg-white-omelette-recipe/1285227/ 2012-02-23 http://avelox.legalview.com/msn/optr-astellas-pact-for-fidaxomicin/1285226/ 2012-02-23 http://avelox.legalview.com/msn/newcardio-presents-results-for-cardiac-safety-research-consortium-blin/1283468/ 2012-02-23 http://avelox.legalview.com/msn/alcon-posts-solid-fourth-quarter-financial-results/1283467/ 2012-02-23 http://avelox.legalview.com/msn/moxifloxacin-oral-route/1283466/ 2012-02-23 http://avelox.legalview.com/msn/gentium-announces-completion-of-preclinical-and-clinical-studies-for-d/1283465/ 2012-02-23 http://avelox.legalview.com/msn/research-and-markets-moxifloxacin-comprehensive-patent-search/1283464/ 2012-02-23 http://avelox.legalview.com/msn/merck-announces-fourth-quarter-and-full-year-2010-financial-results/1283463/ 2012-02-23 http://avelox.legalview.com/msn/research-and-markets-moxifloxacin-comprehensive-patent-search/1283462/ 2012-02-23 http://avelox.legalview.com/msn/optr-astellas-pact-for-fidaxomicin/1283461/ 2012-02-23 http://avelox.legalview.com/msn/vancomycin-inj/1282747/ 2012-02-23 http://avelox.legalview.com/msn/patient-discussions/1282746/ 2012-02-23 http://avelox.legalview.com/msn/dusting-off-old-tb-drug-may-promote-faster-treatment/1282745/ 2012-02-23 http://avelox.legalview.com/msn/rib-x-announces-publication-demonstrating-superior-infection-site-pote/1281983/ 2012-02-23 http://avelox.legalview.com/msn/generic-erosion-of-nine-branded-agents-will-significantly-constrain-gr/1281982/ 2012-02-23 http://avelox.legalview.com/msn/why-an-exhibition-bench/1281981/ 2012-02-23 http://avelox.legalview.com/msn/antibiotics-and-blood-pressure-drug-combos-dangerous-to-older-adults/1281980/ 2012-02-23 http://avelox.legalview.com/msn/john-duddy-vs-matt-vanda/1281979/ 2012-02-23 http://avelox.legalview.com/msn/patient-discussions/1281978/ 2012-02-23 http://avelox.legalview.com/msn/items-in-afp-with-mesh-term-urinary-tract-infections/1280919/ 2012-02-23 http://avelox.legalview.com/msn/alcon-posts-solid-fourth-quarter-financial-results/1280918/ 2012-02-23 http://avelox.legalview.com/msn/moxifloxacin-ophthalmic-route/1280917/ 2012-02-23 http://avelox.legalview.com/msn/eye-bacteria-susceptible-to-newer-antibiotics/1280916/ 2012-02-23 http://avelox.legalview.com/msn/moxifloxacin-oral-route/1280915/ 2012-02-23 http://avelox.legalview.com/msn/ocular-therapeutix-inc-completes-series-d-financing-to-support-phase-i/1280914/ 2012-02-23 http://avelox.legalview.com/msn/fda-has-approved-new-indication-for-avelox-treatment-of-complicated-in/1280913/ 2012-02-23 http://avelox.legalview.com/msn/tuberculosis-tb/1280912/ 2012-02-23 http://avelox.legalview.com/msn/wednesdays-last-word-on-tuesday/1280911/ 2012-02-23 http://avelox.legalview.com/msn/toe-to-toe-with-soccer-star-steve-guppy/1280910/ 2012-02-23 http://avelox.legalview.com/msn/moxifloxacin-alone-equals-combo-regimen-in-pneumonia/1280909/ 2012-02-23 http://avelox.legalview.com/msn/black-hairy-tongue-is-disturbing-but-harmless/1279997/ 2012-02-23 http://avelox.legalview.com/msn/todays-assembly-board-list/1279996/ 2012-02-23 http://avelox.legalview.com/msn/research-and-markets-venezuela-pharmaceuticals-and-healthcare-report-q/1279995/ 2012-02-23 http://avelox.legalview.com/msn/why-it-is-constant-p-a-cloud/1279994/ 2012-02-23 http://avelox.legalview.com/msn/tb-incidence-rate-drops-in-us-but-decline-slows/1279993/ 2012-02-23 http://avelox.legalview.com/msn/ocular-therapeutix-closes-14-million-series-d-financing-round/1279992/ 2012-02-23 http://avelox.legalview.com/msn/ocular-therapeutix-inc-completes-series-d-financing-to-support-phase-i/1279991/ 2012-02-23 http://avelox.legalview.com/msn/ocular-therapeutics-grabs-14m-in-new-round-for-eye-therapies/1279990/ 2012-02-23 http://avelox.legalview.com/msn/research-and-markets-bayer-performance-products-pipeline-and-potential/1279989/ 2012-02-23 http://avelox.legalview.com/msn/fluoroquinolones-for-pneumonia/1279988/ 2012-02-23 http://avelox.legalview.com/msn/moxifloxacin-oral-route/1279987/ 2012-02-23 http://avelox.legalview.com/msn/dont-blow-out-your-knee-because-you-got-a-cold-antibiotics-and-your-jo/1279986/ 2012-02-23 http://avelox.legalview.com/msn/dont-blow-out-your-knee-because-you-got-a-cold-antibiotics-and-your-jo/1279576/ 2012-02-23 http://avelox.legalview.com/msn/dont-blow-out-your-knee-because-you-got-a-cold-antibiotics-and-your-jo/1279212/ 2012-02-23 http://avelox.legalview.com/msn/health-and-wellness-dont-blow-out-your-knee-because-you-got-a-cold-ant/1277137/ 2012-02-23 http://avelox.legalview.com/msn/avelox-can-be-lifestyle-threatening/1273169/ 2012-02-23 http://avelox.legalview.com/msn/ocular-therapeutix-pushes-last-round-to-21m/1272501/ 2012-02-23 http://avelox.legalview.com/msn/rib-x-announces-publication-demonstrating-superior-infection-site-pote/1271839/ 2012-02-23 http://avelox.legalview.com/msn/recently-released-market-study-the-pharmaceutical-market-venezuela/1271017/ 2012-02-23 http://avelox.legalview.com/msn/rib-x-announces-publication-demonstrating-superior-infection-site-pote/1270619/ 2012-02-23 http://avelox.legalview.com/msn/the-pharmaceutical-market-venezuela-new-market-report-published/1270221/ 2012-02-23 http://avelox.legalview.com/msn/struggling-to-breathe/1269294/ 2012-02-23 http://avelox.legalview.com/msn/dr-hani-sorour-returns-to-practice-family-medicine-in-virginia/1268716/ 2012-02-23 http://avelox.legalview.com/msn/dr-hani-sorour-returns-to-practice-family-medicine-in-virginia/1268088/ 2012-02-23 http://avelox.legalview.com/msn/dr-hani-sorour-returns-to-practice-family-medicine-in-virginia/1267865/ 2012-02-23 http://avelox.legalview.com/msn/pneumonia-pipeline-assessment-and-market-forecasts-to-2017-now-availab/1267226/ 2012-02-23 http://avelox.legalview.com/msn/side-effects-of-avalox/1265832/ 2012-02-23 http://avelox.legalview.com/msn/fda-drug-safety-communication-abnormal-heart-rhythms-associated-with-u/1264685/ 2012-02-23 http://avelox.legalview.com/msn/struggling-to-breathe/1264446/ 2012-02-23 http://avelox.legalview.com/msn/fda-drug-safety-communication-abnormal-heart-rhythms-associated-with-u/1264026/ 2012-02-23 http://avelox.legalview.com/msn/avelox-tendon-ruptures/1264025/ 2012-02-23 http://avelox.legalview.com/msn/newcardio-presents-results-for-cardiac-safety-research-consortium-blin/1263722/ 2012-02-23 http://avelox.legalview.com/msn/cancer-drugs-too-costly-for-scots-patients/1263003/ 2012-02-23 http://avelox.legalview.com/msn/newcardio-presents-results-for-cardiac-safety-research-consortium-blin/1263002/ 2012-02-23 http://avelox.legalview.com/msn/respiratory-infection-may-be-a-big-killer-by-2020/1262719/ 2012-02-23 http://avelox.legalview.com/msn/newcardio-presents-results-for-cardiac-safety-research-consortium-blin/1262452/ 2012-02-23 http://avelox.legalview.com/msn/newcardio-presents-results-for-cardiac-safety-research-consortium-blin/1262266/ 2012-02-23 http://avelox.legalview.com/msn/generic-erosion-of-nine-branded-agents-will-significantly-constrain-gr/1262265/ 2012-02-23 http://avelox.legalview.com/msn/longer-term-phase-iii-data-show-novartis-drug-tasigna-continues-to-sur/1261982/ 2012-02-23 http://avelox.legalview.com/msn/longer-term-phase-iii-data-show-novartis-drug-tasigna-continues-to-sur/1261546/ 2012-02-23 http://avelox.legalview.com/msn/clinical-data-inc-announces-vilazodone-data-presented-at-american-soci/1261545/ 2012-02-23 http://avelox.legalview.com/msn/fluoroquinolones-as-a-cause-of-tendon-disorders/1261264/ 2012-02-23 http://avelox.legalview.com/msn/safety-concerns-with-fluoroquinolones-increased-risk-of-tendinitis-and/1261263/ 2012-02-23 http://avelox.legalview.com/msn/longer-term-phase-iii-data-show-novartis-drug-tasigna-continues-to-sur/1260878/ 2012-02-23 http://avelox.legalview.com/msn/medical-society-guidelines-and-recommendations-from-hospital-infectiou/1259413/ 2012-02-23 http://avelox.legalview.com/msn/new-antibiotic-policy-may-be-introduced-in-3-delhi-hospitals/1258963/ 2012-02-23 http://avelox.legalview.com/msn/wider-access-to-ms-treatments/1258726/ 2012-02-23 http://avelox.legalview.com/msn/peoples-pharmacy/1258725/ 2012-02-23 http://avelox.legalview.com/msn/africa-new-drugs-to-speed-tb-treatment/1258288/ 2012-02-23 http://avelox.legalview.com/msn/modulation-of-salmonella-gene-expression-by-subinhibitory-concentratio/1257697/ 2012-02-23 http://avelox.legalview.com/msn/pneumonia-pipeline-assessment-and-market-forecasts-to-2017-new-market/1257696/ 2012-02-23 http://avelox.legalview.com/msn/new-antibiotic-policy-may-be-introduced-in-3-delhi-hospitals/1256394/ 2012-02-23 http://avelox.legalview.com/msn/lemon-slices-teeming-with-germs/1256393/ 2012-02-23 http://avelox.legalview.com/msn/new-tb-drugs-on-the-horizon/1256062/ 2012-02-23 http://avelox.legalview.com/msn/new-drugs-to-speed-tb-treatment/1256061/ 2012-02-23 http://avelox.legalview.com/msn/graedon-vicks-vaporub-used-to-get-rid-of-nail-fungus/1256060/ 2012-02-23 http://avelox.legalview.com/msn/germs-with-your-lemon-wedge/1256059/ 2012-02-23 http://avelox.legalview.com/msn/st-joes-expands-antibiotic-stewardship-program/1255741/ 2012-02-23 http://avelox.legalview.com/msn/st-joes-expands-antibiotic-stewardship-program-over-c-difficile-outbre/1255740/ 2012-02-23 http://avelox.legalview.com/msn/why-give-up-when-sinus-contamination-anti-biotics-can-rescue/1255739/ 2012-02-23 http://avelox.legalview.com/msn/peoples-pharmacy/1255738/ 2012-02-23 http://avelox.legalview.com/msn/st-joes-expands-antibiotic-stewardship-program-over-c-difficile-outbre/1255350/ 2012-02-23 http://avelox.legalview.com/msn/tb-alliance-launches-first-clinical-trial-of-a-novel-tb-drug-regimen/1255349/ 2012-02-23 http://avelox.legalview.com/msn/south-africa-new-tb-treatment-on-trial/1254987/ 2012-02-23 http://avelox.legalview.com/msn/global-body-begins-tb-drug-trials/1254985/ 2012-02-23 http://avelox.legalview.com/msn/tb-alliance-launches-first-clinical-trial-of-a-novel-tb-drug-regimen/1254680/ 2012-02-23 http://avelox.legalview.com/msn/newcardio-to-present-results-of-qtinno-performance-on-cardiac-safety-r/1254679/ 2012-02-23 http://avelox.legalview.com/msn/tb-alliance-launches-first-clinical-trial-of-a-novel-tb-drug-regimen/1254262/ 2012-02-23 http://avelox.legalview.com/msn/map-pharma-reveals-results-from-thorough-qt-trial-of-levadex-quick-fac/1254261/ 2012-02-23 http://avelox.legalview.com/msn/map-pharmaceuticals-announces-successful-results-for-levadex-thorough/1254260/ 2012-02-23 http://avelox.legalview.com/msn/ocular-therapeutix-completes-proof-of-principle-study-with-moxifloxaci/1250541/ 2012-02-23 http://avelox.legalview.com/msn/fda-drug-safety-communication-invirase-saquinavir-labels-now-contain-u/1249068/ 2012-02-23 http://avelox.legalview.com/msn/ocular-therapeutix-completes-proof-of-principle-clinical-study-with-mo/1246243/ 2012-02-23 http://avelox.legalview.com/msn/ocular-therapeutix-completes-eye-drug-delivery-study/1245887/ 2012-02-23 http://avelox.legalview.com/msn/ocular-therapeutix-completes-proof-of-principle-study-with-moxifloxaci/1245504/ 2012-02-23 http://avelox.legalview.com/msn/rib-x-pharmaceuticals-presents-positive-preclinical-data-for-delafloxa/1236478/ 2012-02-23 http://avelox.legalview.com/msn/rib-x-pharmaceuticals-presents-data-supporting-delafloxacin-as-a-poten/1236477/ 2012-02-23 http://avelox.legalview.com/msn/research-and-markets-venezuela-pharmaceuticals-and-healthcare-report-q/1236476/ 2012-02-23 http://avelox.legalview.com/msn/research-and-markets-venezuela-pharmaceuticals-and-healthcare-report-q/1236097/ 2012-02-23 http://avelox.legalview.com/msn/map-pharmaceuticals-announces-all-non-asthmatic-patients-complete-trea/1233740/ 2012-02-23 http://avelox.legalview.com/msn/rib-x-pharmaceuticals-to-present-15-abstracts-covering-next-generation/1232912/ 2012-02-23 http://avelox.legalview.com/msn/cepheid-revolutionary-test-spots-tb-super-bugs-in-90-minutes/1230813/ 2012-02-23 http://avelox.legalview.com/msn/cepheids-revolutionary-test-identifies-tb-within-two-hours/1230394/ 2012-02-23 http://avelox.legalview.com/msn/unusual-partnership-gives-hope-to-those-suffering-from-the-symptoms-of/1228833/ 2012-02-23 http://avelox.legalview.com/msn/usa-running-a-close-second-to-salmonella/1227410/ 2012-02-23 http://avelox.legalview.com/msn/biopsy-proven-acute-interstitial-nephritis-after-treatment-with-moxifl/1227137/ 2012-02-23 http://avelox.legalview.com/msn/antibiotic-armageddon-now/1222551/ 2012-02-23 http://avelox.legalview.com/msn/venezuela-pharmaceuticals-and-healthcare-report-q3-2010-new-market-rep/1221764/ 2012-02-23 http://avelox.legalview.com/msn/astellas-uk-boosts-anti-infectives-portfolio-with-avelox-moxifloxacin/1218391/ 2012-02-23 http://avelox.legalview.com/msn/astellas-uk-boosts-anti-infectives-portfolio-with-avelox-moxifloxacin/1218390/ 2012-02-23 http://avelox.legalview.com/msn/astellas-uk-boosts-anti-infectives-portfolio-with-avelox-moxifloxacin/1218068/ 2012-02-23 http://avelox.legalview.com/msn/bayer-corp-revenue-sales-rise-but-net-income-falls/1216622/ 2012-02-23 http://avelox.legalview.com/msn/trial-to-reduce-tb-treatment-time-from-six-to-four-months/1215827/ 2012-02-23 http://avelox.legalview.com/msn/bayer-increases-sales-and-earnings-in-the-second-quarter/1215432/ 2012-02-23 http://avelox.legalview.com/msn/non-profit-staffing-remains-problematic/1214231/ 2012-02-23 http://avelox.legalview.com/msn/new-market-study-published-venezuela-pharmaceuticals-healthcare-report/1214230/ 2012-02-23 http://avelox.legalview.com/msn/new-market-study-published-venezuela-pharmaceuticals-healthcare-report/1213524/ 2012-02-23 http://avelox.legalview.com/msn/new-report-pneumonia-drug-pipeline-analysis-and-market-forecasts-to-20/1212863/ 2012-02-23 http://avelox.legalview.com/msn/add-your-knowledge-posts-written-by-tamoroso/1189068/ 2012-02-23 http://avelox.legalview.com/msn/shionogi-pipeline-products-performance-and-potential/1189067/ 2012-02-23 http://avelox.legalview.com/msn/william-bishai-named-to-head-new-tb-hiv-institute-in-south-africa/1188221/ 2012-02-23 http://avelox.legalview.com/msn/new-market-report-pneumonia-drug-pipeline-analysis/1186411/ 2012-02-23 http://avelox.legalview.com/msn/staccator-loxapine-az-004-reduced-signs-and/1186035/ 2012-02-23 http://avelox.legalview.com/msn/staccator-loxapine-az-004-reduced-signs-and/1185321/ 2012-02-23 http://avelox.legalview.com/msn/william-bishai-named-to-head-new-tb-hiv-institute-in/1184910/ 2012-02-23 http://avelox.legalview.com/msn/staccator-loxapine-az-004-reduced-signs-and/1184909/ 2012-02-23 http://avelox.legalview.com/msn/research-and-markets-pneumonia-drug-pipeline-analysis-and-market/1184454/ 2012-02-23 http://avelox.legalview.com/msn/pneumonia-therapeutics-market-is-forecast-to-decline/1184058/ 2012-02-23 http://avelox.legalview.com/msn/the-relationship-between-inpatient-fluoroquinolone-use/1182537/ 2012-02-23 http://avelox.legalview.com/msn/earthquake-in-haiti-disaster-management-resources/1182536/ 2012-02-23 http://avelox.legalview.com/msn/globaldata-s-new-report-on-global-pneumonia-market/1182535/ 2012-02-23 http://avelox.legalview.com/msn/research-and-markets-pneumonia-drug-pipeline/1182534/ 2012-02-23 http://avelox.legalview.com/msn/pneumonia-drug-pipeline-analysis-and-market-forecasts/1178338/ 2012-02-23 http://avelox.legalview.com/msn/infections-infestations-bacterial-infections/1176837/ 2012-02-23 http://avelox.legalview.com/msn/pneumonia-drug-pipeline-analysis-and-market-forecasts/1176836/ 2012-02-23 http://avelox.legalview.com/msn/pneumonia-drug-pipeline-analysis-and-market-forecasts/1176355/ 2012-02-23 http://avelox.legalview.com/msn/alcon-inc-q1-2010-earnings-call-transcript/1171018/ 2012-02-23 http://avelox.legalview.com/msn/alcon-inc-q1-2010-earnings-call-transcript/1169627/ 2012-02-23 http://avelox.legalview.com/msn/research-and-markets-venezuela-pharmaceuticals-and/1169626/ 2012-02-23 http://avelox.legalview.com/msn/alcon-inc-q1-2010-earnings-call-transcript/1169248/ 2012-02-23 http://avelox.legalview.com/msn/research-and-markets-venezuela-pharmaceuticals-and/1169247/ 2012-02-23 http://avelox.legalview.com/msn/shionogi-pipeline-products-performance-and-potential/1159897/ 2012-02-23 http://avelox.legalview.com/msn/venezuela-pharmaceuticals-and-healthcare-report-q2-2010/1155641/ 2012-02-23 http://avelox.legalview.com/msn/almost-over-reconciliation-passes-senate-56-43/1154546/ 2012-02-23 http://avelox.legalview.com/msn/canadian-avelox-label-now-warns-of-liver-damage/1154545/ 2012-02-23 http://avelox.legalview.com/msn/consumption-of-avelox-may-lead-to-liver-injury/1154208/ 2012-02-23 http://avelox.legalview.com/msn/updated-labelling-for-antibiotic-avelox-moxifloxacin/1154207/ 2012-02-23 http://avelox.legalview.com/msn/avelox-liver-injury-warning-issued-in-canada/1153947/ 2012-02-23 http://avelox.legalview.com/msn/antibiotic-may-be-linked-to-liver-problems/1153691/ 2012-02-23 http://avelox.legalview.com/msn/updated-labelling-for-antibiotic-avelox-moxifloxacin/1153690/ 2012-02-23 http://avelox.legalview.com/msn/world-tuberculosis-day-2010-on-the-move-against/1153689/ 2012-02-23 http://avelox.legalview.com/msn/canadians-spending-more-time-surfing-net-than-watching/1153688/ 2012-02-23 http://avelox.legalview.com/msn/thespeccom-healthfitness-health-news/1153687/ 2012-02-23 http://avelox.legalview.com/msn/thespeccom-breakingnews-antibiotic-avelox-may-be/1153686/ 2012-02-23 http://avelox.legalview.com/msn/antibiotic-avelox-may-be-linked-to-rare-liver-injury/1153685/ 2012-02-23 http://avelox.legalview.com/msn/updated-labelling-for-antibiotic-avelox-moxifloxacin/1153684/ 2012-02-23 http://avelox.legalview.com/msn/world-tuberculosis-day-2010-on-the-move-against/1153452/ 2012-02-23 http://avelox.legalview.com/msn/novartis-drug-tasignar-receives-fda-priority-review-for-newly/1144978/ 2012-02-23 http://avelox.legalview.com/msn/novartis-drug-tasignar-receives-fda-priority-review-for-newly/1144430/ 2012-02-23 http://avelox.legalview.com/msn/novartis-drug-tasigna-receives-fda-priority-review-for-newly-diagnosed/1144199/ 2012-02-23 http://avelox.legalview.com/msn/novartis-drug-tasignar-receives-fda-priority-review-for-newly/1144198/ 2012-02-23 http://avelox.legalview.com/msn/new-virulent-strain-of-mrsa-poses-renewed-antibiotic-resistance/1140710/ 2012-02-23 http://avelox.legalview.com/msn/new-virulent-strain-of-mrsa-poses-renewed-antibiotic-resistance/1140387/ 2012-02-23 http://avelox.legalview.com/msn/health-experts-warn-new-mrsa-strain-growing-more-frequent-out-of/1140149/ 2012-02-23 http://avelox.legalview.com/msn/two-drugs-that-slow-mrsas-resistance-to-treatment-identified/1140148/ 2012-02-23 http://avelox.legalview.com/msn/new-virulent-strain-of-mrsa-poses-renewed-antibiotic-resistance/1140147/ 2012-02-23 http://avelox.legalview.com/msn/rib-x-pharmaceuticals-and-mgh-enter-into-collaborative-research/1139916/ 2012-02-23 http://avelox.legalview.com/msn/health-experts-warn-new-mrsa-strain-growing-more-frequent-out-of/1139915/ 2012-02-23 http://avelox.legalview.com/msn/new-virulent-strain-of-mrsa-poses-renewed-antibiotic-resistance/1139914/ 2012-02-23 http://avelox.legalview.com/msn/generic-levaquin-is-in-the-pipeline/1139155/ 2012-02-23 http://avelox.legalview.com/msn/rib-x-pharmaceuticals-enters-into-collaborative-agreement-on/1139154/ 2012-02-23 http://avelox.legalview.com/msn/report-on-the-community-acquired-pneumonia-drug-market/1138629/ 2012-02-23 http://avelox.legalview.com/msn/novartis-tasignar-trial-shows-superior-results-to-gleevecr-in/1138410/ 2012-02-23 http://avelox.legalview.com/msn/hopes-of-new-drugs-vaccines-for-tuberculosis/1138409/ 2012-02-23 http://avelox.legalview.com/msn/novartis-tasignar-trial-shows-superior-results-to-gleevecr-in/1137965/ 2012-02-23 http://avelox.legalview.com/msn/new-stedesa-clinical-data-presented-at-american-epilepsy-society/1137689/ 2012-02-23 http://avelox.legalview.com/msn/novartis-tasignar-trial-shows-superior-results-to-gleevecr-in/1137688/ 2012-02-23 http://avelox.legalview.com/msn/hopes-of-new-drugs-vaccines-for-tuberculosis/1137687/ 2012-02-23 http://avelox.legalview.com/msn/significant-potential-of-late-and-mid-stage-novartis-hematology/1137303/ 2012-02-23 http://avelox.legalview.com/msn/significant-potential-of-late-and-mid-stage-novartis-hematology/1136817/ 2012-02-23 http://avelox.legalview.com/msn/significant-potential-of-late-and-mid-stage-novartis-hematology/1136539/ 2012-02-23 http://avelox.legalview.com/msn/venezuela-aims-to-annul-patents-for-antibiotic/1136138/ 2012-02-23 http://avelox.legalview.com/msn/venezuela-invalidates-patents-registered-by-bayer-for-its-antibiotic/1135761/ 2012-02-23 http://avelox.legalview.com/msn/venezuela-aims-to-annul-patents-for-antibiotic/1134887/ 2012-02-23 http://avelox.legalview.com/msn/business-watch/1134615/ 2012-02-23 http://avelox.legalview.com/msn/venezuelan-government-plans-to-annul-bayer-healthcare-antibiotic/1134614/ 2012-02-23 http://avelox.legalview.com/msn/celebrex-commercial/1134361/ 2012-02-23 http://avelox.legalview.com/msn/alcohol-and-valium/1134360/ 2012-02-23 http://avelox.legalview.com/msn/venezuela-aims-to-annul-patents-for-antibiotic/1134359/ 2012-02-23 http://avelox.legalview.com/msn/bayer-exec-says-company-will-hike-rd-spending/1132360/ 2012-02-23 http://avelox.legalview.com/msn/a-shock-to-the-system/1131550/ 2012-02-23 http://avelox.legalview.com/msn/schering-plough-reports-financial-results-for-2009-third-quarter/1128447/ 2012-02-23 http://avelox.legalview.com/msn/drugs-medications-levofloxacin-oral/1126610/ 2012-02-23 http://avelox.legalview.com/msn/novartis-drug-tasignar-meets-primary-endpoint-in-pivotal-trial/1125865/ 2012-02-23 http://avelox.legalview.com/msn/schering-plough-reports-financial-results-for-2009-third-quarter/1125864/ 2012-02-23 http://avelox.legalview.com/msn/avelox-antibiotic-linked-to-tendon-ruptures/1125863/ 2012-02-23 http://avelox.legalview.com/msn/novartis-drug-tasignar-meets-primary-endpoint-in-pivotal-trial/1125142/ 2012-02-23 http://avelox.legalview.com/msn/recent-comments/1124734/ 2012-02-23 http://avelox.legalview.com/msn/aeterna-zentaris-thorough-qt-trial-with-cetrorelix-in-benign/1123710/ 2012-02-23 http://avelox.legalview.com/msn/aeterna-zentaris-thorough-qt-trial-with-cetrorelix-in-benign/1121103/ 2012-02-23 http://avelox.legalview.com/msn/rib-x-pharmaceuticals-receives-award-from-niaid-to-develop-antibiotic/1120478/ 2012-02-23 http://avelox.legalview.com/msn/xenoport-reports-second-quarter-financial-results/1119284/ 2012-02-23 http://avelox.legalview.com/msn/treasuries-decline-as-retail-sales-surge-most-in-three-years/1119012/ 2012-02-23 http://avelox.legalview.com/msn/some-antibiotics-overprescribed-effects-not-widely-known/1118655/ 2012-02-23 http://avelox.legalview.com/msn/related-to-a-weak-pound/1116965/ 2012-02-23 http://avelox.legalview.com/msn/some-antibiotics-can-cause-double-vision/1114901/ 2012-02-23 http://avelox.legalview.com/msn/new-tb-antibiotic-is-proving-worthy-of-a-fight/1110692/ 2012-02-23 http://avelox.legalview.com/msn/newcardio-announces-commercial-launch-of-qtinno-release-version-10/1110691/ 2012-02-23 http://avelox.legalview.com/msn/software-suite-for-comprehensive-analysis-of-cardiac-safety-released/1110690/ 2012-02-23 http://avelox.legalview.com/msn/newcardio-announces-commercial-launch-of-qtinno-release-version-10/1110223/ 2012-02-23 http://avelox.legalview.com/msn/software-suite-for-comprehensive-analysis-of-cardiac-safety-released/1110222/ 2012-02-23 http://avelox.legalview.com/msn/blocking-mechanism-found-for-antibiotic-resistance-in-bacteria/1108051/ 2012-02-23 http://avelox.legalview.com/msn/instead-of-moving-on-johnson-can-move-up-pga-leaderboard/1106809/ 2012-02-23 http://avelox.legalview.com/msn/schering-plough-reports-financial-results-for-2009-second-quarter/1106808/ 2012-02-23 http://avelox.legalview.com/msn/older-antibiotic-gains-new-respect-as-potent-treatment-for/1097368/ 2012-02-23 http://avelox.legalview.com/msn/the-ignored-risks-of-americas-most-popular-antibiotics/1097367/ 2012-02-23 http://avelox.legalview.com/msn/family-doctor-can-medication-cause-ruptured-tendons/1092568/ 2012-02-23 http://avelox.legalview.com/msn/new-antibiotic-clears-hurdle-in-tb-treatment/1089427/ 2012-02-23 http://avelox.legalview.com/msn/higher-drug-doses-needed-to-defeat-tuberculosis-in-overweight-and/1089426/ 2012-02-23 http://avelox.legalview.com/msn/new-antibiotic-could-shorten-tb-treatment/1089425/ 2012-02-23 http://avelox.legalview.com/msn/new-antibiotic-moxifloxacin-could-shorten-tuberculosis-treatment/1089424/ 2012-02-23 http://avelox.legalview.com/msn/case-18-2009-a-24-year-old-woman-with-aids-and-tuberculosis-with/1089423/ 2012-02-23 http://avelox.legalview.com/msn/fda-approvals-fanapt-and-cycloset/1089422/ 2012-02-23 http://avelox.legalview.com/msn/alexza-reports-2009-second-quarter-financial-results-and-updates/1089421/ 2012-02-23 http://avelox.legalview.com/msn/xenoport-reports-second-quarter-financial-results/1089420/ 2012-02-23 http://avelox.legalview.com/msn/doctors-face-pressure-to-disclose-all-side-pay/1089419/ 2012-02-23 http://avelox.legalview.com/msn/what-can-be-done-to-prevent-moxifloxacin-induced-anxiety/1089418/ 2012-02-23 http://avelox.legalview.com/msn/schering-plough-q4-2008-earnings-call-transcript/1089417/ 2012-02-23 http://avelox.legalview.com/msn/if-youre-going-to-boycott-israel-do-it-properly/1089416/ 2012-02-23 http://avelox.legalview.com/msn/arthritis-can-follow-psoriasis/1089415/ 2012-02-23 http://avelox.legalview.com/msn/dr-gott-can-drug-cause-ruptured-tendons/1089414/ 2012-02-23 http://avelox.legalview.com/msn/dont-be-ill-take-your-pill/1089413/ 2012-02-23 http://avelox.legalview.com/msn/antibiotics-to-avoid-like-the-plague-due-to-fdas-oversight-failure/1089412/ 2012-02-23 http://avelox.legalview.com/msn/east-strodusburg-university-police-officer-accused-of-illegally/1089411/ 2012-02-23 http://avelox.legalview.com/msn/learn-about-the-world-ophthalmic-pharmaceutical-drugs-market/1087706/ 2012-02-23 http://avelox.legalview.com/msn/rib-x-pharmaceuticals-reports-positive-top-line-results-from-phase-2/1086768/ 2012-02-23 http://avelox.legalview.com/msn/rib-x-pharmaceuticals-reports-positive-top-line-results-from-phase-2/1086623/ 2012-02-23 http://avelox.legalview.com/msn/protecting-public-health-is-a-government-responsibility/1086497/ 2012-02-23